kt 5823 has been researched along with glutamic acid in 7 studies
| Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (glutamic acid) | Trials (glutamic acid) | Recent Studies (post-2010) (glutamic acid) |
|---|---|---|---|---|---|
| 317 | 0 | 59 | 41,757 | 452 | 12,876 |
| Protein | Taxonomy | kt 5823 (IC50) | glutamic acid (IC50) |
|---|---|---|---|
| Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | Rattus norvegicus (Norway rat) | 0.821 | |
| Chain A, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.821 | |
| Chain B, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.821 | |
| Metabotropic glutamate receptor 8 | Homo sapiens (human) | 0.0057 | |
| Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | 0.07 | |
| Glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor 2 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor 3 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor 4 | Rattus norvegicus (Norway rat) | 0.5885 | |
| Glutamate receptor ionotropic, kainate 1 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, kainate 2 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor 1 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor 2 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor 3 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | 0.38 | |
| Excitatory amino acid transporter 1 | Homo sapiens (human) | 207 | |
| Glutamate receptor 4 | Homo sapiens (human) | 0.613 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, kainate 4 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, kainate 5 | Rattus norvegicus (Norway rat) | 0.38 | |
| Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | 0.07 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.1533 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.1533 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sluka, KA; Willis, WD | 1 |
| Geiger, JD; Guo, ZH; Mattson, MP | 1 |
| Fujikawa, H; Kanno, T; Nagata, T; Nishizaki, T | 1 |
| Fukuda, M; Kanamori, A; Naka, M; Nakamura, M; Negi, A | 1 |
| Bao, L; Gong, LQ; Li, KC; Li, ZY; Lin, LB; Liu, XJ; Lu, YJ; Xiao, HS; Yao, JR; Zhang, FX; Zhang, X; Zhang, XH | 1 |
| Huang, WJ; Lin, TY; Lu, CW; Wang, SJ | 1 |
| Deng, QQ; Liu, LL; Weng, SJ; Yang, XL; Zhong, YM | 1 |
7 other study(ies) available for kt 5823 and glutamic acid
| Article | Year |
|---|---|
Increased spinal release of excitatory amino acids following intradermal injection of capsaicin is reduced by a protein kinase G inhibitor.
Topics: Alkaloids; Animals; Aspartic Acid; Capsaicin; Carbazoles; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Enzyme Inhibitors; Glutamic Acid; Indoles; Injections, Intradermal; Isoquinolines; Male; Rats; Rats, Sprague-Dawley; Spinal Cord; Sulfonamides | 1998 |
Secreted form of amyloid precursor protein enhances basal glucose and glutamate transport and protects against oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apoptosis; Biological Transport; Carbazoles; Cerebral Cortex; Cyclic GMP; Enzyme Inhibitors; Female; Ferrous Compounds; Glucose; Glutamic Acid; Indoles; Lipid Peroxidation; Neurons; Neurotoxins; Oxidative Stress; Rats; Rats, Sprague-Dawley; Synapses; Synaptosomes; Tritium | 1999 |
The phosphodiesterase III inhibitor olprinone inhibits hippocampal glutamate release via a cGMP/PKG pathway.
Topics: Animals; Calcium; Carbazoles; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Excitatory Postsynaptic Potentials; Glutamic Acid; Hippocampus; Imidazoles; In Vitro Techniques; Isoquinolines; Male; Membrane Potentials; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Potassium; Protein Kinase Inhibitors; Pyramidal Cells; Pyridones; Rats; Rats, Wistar; Receptors, AMPA; Signal Transduction; Sulfonamides | 2008 |
Tafluprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo.
Topics: Animals; Apoptosis; Calcium; Calcium Channel Blockers; Carbazoles; Caspase 3; Cell Line; Cell Survival; Culture Media, Serum-Free; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Glutamic Acid; In Vitro Techniques; Instillation, Drug; Intracellular Membranes; Intraocular Pressure; Male; Nerve Crush; Neuroprotective Agents; Ophthalmic Solutions; Optic Nerve; Prostaglandins F; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Retinal Ganglion Cells; Time Factors | 2009 |
Inhibition of inflammatory pain by activating B-type natriuretic peptide signal pathway in nociceptive sensory neurons.
Topics: Analysis of Variance; Animals; Antibodies; Biophysical Phenomena; Calcitonin Gene-Related Peptide; Carbazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Freund's Adjuvant; Ganglia, Spinal; Gene Expression Regulation; Glutamic Acid; Hyperalgesia; Inflammation; Lectins; Male; Membrane Potentials; Natriuretic Peptide, Brain; Pain; Pain Measurement; Patch-Clamp Techniques; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Atrial Natriuretic Factor; Sensory Receptor Cells; Signal Transduction; Time Factors | 2010 |
Involvement of the cGMP pathway in the osthole-facilitated glutamate release in rat hippocampal nerve endings.
Topics: Animals; Carbazoles; Coumarins; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 5; Glutamic Acid; Guanylate Cyclase; Hippocampus; Male; Nerve Endings; Rats; Rats, Sprague-Dawley; Synaptic Transmission; Thionucleotides | 2012 |
Activation of the sigma receptor 1 modulates AMPA receptor-mediated light-evoked excitatory postsynaptic currents in rat retinal ganglion cells.
Topics: Animals; Calcium; Carbazoles; Cells, Cultured; Central Nervous System Agents; Cyclic GMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethylenediamines; Excitatory Postsynaptic Potentials; Glutamic Acid; Light; Male; Patch-Clamp Techniques; Phenazocine; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, sigma; Retinal Ganglion Cells; Tissue Culture Techniques; Vision, Ocular; Voltage-Sensitive Dye Imaging | 2016 |